Name: David H. Barad, MD, MS Current Licensure - Center for ...

CV David Barad Page 1
CURRICULUM VITAE
Name: David H. Barad, MD, MS
Date of birth: March 29, 1950
Citizenship: United States of America
Address: Office:
Center for Human Reproduction
21 East 69 th Street
New York, NY 10021
Telephone ........................................................ (212) 994-4400
Fax: .................................................................. (212) 994-4499
Email ........................................................ dbarad@thechr.com
Last updated: 4/4/2012
Current Licensure: # Date Registered through
New York State Medical License 140352-1 Oct 1979 Feb 28, 2013
New Jersey Medical License 25MA08029900 Inactive
DEA Registration BB8288676 May 2003 July 31, 2012

Education:
School Location Major Degree Date
Rutgers New Brunswick,
NJ
Biology BA June 1972
Boston University Graduate
School
Rutgers Medical School (Robert
Wood Johnson)
Albert Einstein College of
Medicine
Master Theses:
Boston, Mass
Piscataway, NJ
CV David Barad Page 2
Comparative Endocrinology
/Biology
MA June 1974
Medicine MD June 2, 1978
Bronx, NY Clinical Research Training
Program
MS June 4, 2003
Masters of Arts in Comparitive Endocrinology – Boston University
Circulating plasma estrogen levels in the female turtle chrysemys picta during its annual reproductive
cycle and following gonadotropin treatment - 1975.
Masters of Science in Clinical Research – Albert Einstein College of Medicine 2003
Association of hypertension and history of hysterectomy among menopausal women. – 2003
Post Graduate Clinical education:
Hospital Location Program PG year Dates
Metropolitan Hospital New York, New
York
Sloane Hospital for Women/ Columbia
Presbyterian Medical Center
Sloane Hospital for Women/ Columbia
Presbyterian Medical Center
Brigham and Women's Hospital
New York, New
York
New York, New
York
75 Francis Street
Boston,
Massachusetts
Obstetrics &
Gynecology
Internship
Obstetrics &
Gynecology
Internship
Obstetrics &
Gynecology
Residency
Fellow in Obstetrics &
Gynecology
(Reproductive
Endocrinology)
PGY 1
(6mos)
PGY 1
(6mos)
PGY 2
PGY 3
PGY 4
(Chief)
PGY 5
PGY 6
7/1/78 -
12/31/78
1/1/79 -
6/30/79
7/1/79 -
6/30/82
7/1/82 -
6/30/84

Professional employment and Hospital appointments:
Professional employment
Position
CV David Barad Page 3
Department Dates
Director of Assisted Reproduction Center for Human Reproduction, NYC
Associate Clinical Professor Epidemiology and Social Medicine
Albert Einstein College of Medicine
Bronx, New York
Associate Clinical Professor Obstetrics, Gynecology and Women’s Health
Albert Einstein College of Medicine
Bronx, New York
Director of Gynecology
Community Hospital at Dobbs Ferry
Dobbs Ferry, New York 10522
Associate Professor Obstetrics, Gynecology and Women’s Health
Albert Einstein College of Medicine
Bronx, New York
Director Division of Reproductive Endocrinology
And Infertility
Department of Obstetrics, Gynecology & Women’s
Health
Albert Einstein College of Medicine
Bronx, New York
Director Division of Reproductive Endocrinology and Infertility
Department of Obstetrics, Gynecology & Women’s
Health
Montefiore Medical Center
Bronx, New York
Acting Director Division of Reproductive Endocrinology And Infertility
Department of Obstetrics & Gynecology
Albert Einstein College of Medicine
Bronx, New York
Head of Reproductive
Endocrinology
Bronx Municipal Hospital Center
Bronx, New York
Assistant Professor Obstetrics & Gynecology
Albert Einstein College of Medicine
Bronx, New York
Clinical Instructor Obstetrics & Gynecology
Harvard Medical School
Boston, Massachusetts
7/03 - Present
5/05 - Present
4/01 – Present
1998- 4/01
7/1/90 – 4/01
12/85 – 9/98
12/85- 4/01
5/85 - 12/85
7/1/84 – 7/98
7/1/84 - 7/1/90
7/1/82 - 6/30/84

Hospital Appointments
Institution Address Depart./ Staff Dates
Service Category
St. Luke’s-Roosevelt 555 W. 57th Street, New York, NY OB/GYN Attending May 2004 -
Hospital Center
10019
Present
Community Hosp at Dobbs 128 Ashford Ave Dobbs Ferry, NY Gynecology Director 1995 - 2001
Ferry
10522-1924
Montefiore Medical Center 1825 Eastchester Rd Bronx, NY 10461 Obs & Gyn Attending 1990 – 2001
Bronx Municipal Hospital
Center
Brigham and Women’s
Hospital
Board Certification
Pelham Parkway South & Eastchester
Rd, Bronx, NY
CV David Barad Page 4
Obs & Gyn Attending 1984 - 1989
75 Francis St Boston, MA 02115 Obs & Gyn Instructor 7/82 – 5/84
American Board of Obstetrics and
Gynecology
Board Certified 1985
American Board of Obstetrics and
Gynecology
Re-certification 1996
Reproductive Endocrinology Written Exam Jun 1986
American Board of Obstetrics and
Gynecology
Board Certified Reproductive Endocrinology Dec 1988
American Board of Obstetrics and
Gynecology
Accreditation Council for Gynecologic
Endoscopy
Re-certification Feb 1996
Certified in Operative Laparoscopy and Operative
Hysteroscopy
1996

Professional Society Memberships
American Society of Reproductive Medicine
CV David Barad Page 5
ASRM – Reproductive Biology Special Interest Group
American Medical Association
New York State Medical Association
American Association of Gynecological Laparoscopists
American College of Obstetrics & Gynecology
Society of Reproductive Endocrinologists
Society of Assisted Reproductive Technology
New York Obstetrical Society
Society of the Slone Hospital for Women
Awards and Honors Howard C. Taylor Award for Teaching Excellence
Columbia-Presbyterian Medical Center
Sloane Hospital for Women - 1982
New York, New York
Residents Teaching Award
Albert Einstein College of Medicine - spring 1985
Bronx, New York
Resolve of NYC Chapter Award - October 1996
Grand Hyatt, New York City
American Infertility Association Award – October 1999
Grand Hyatt, New York City

Other Professional Activities
Advisory Boards
Journal Review
CV David Barad Page 6
Ad Hoc Review: RFA-AG-94-002 "Menopause and Health in Aging Women" April 12-
13, 1994
NHLBI Special Emphasis Panel: RFP-NHLBI-HC-94-16 & 17 "Angiographic Trial in
Women" September 26-27, 1994
P&P HRT Special Interest Group – Women’s Health Initiative (1997 – present)
Hormone Replacement Committee – Women’s Health Initiative (1997 – present)
Hormone Trials Advisory Committee Chair – Women’s Health Initiative (2002 – present)
Steering Committee – Women’s Health Initiative (2002 – present)
New York State Task Force on Life and the Law – Advisory Group on Reproductive
Technologies (1999 - 2000) Consent for ART and Donor services.
Co-Chair – HRT and CaD adherence and Retention Conference – Women’s Health
Initiative (1999 - 2000)
Chair – HRT – Report of interval findings in the Women’s Health Initiative to
participants. – Women’s Health Initiative (2000)
Co-Chair Women’s Health Initiative Clinical Trial – Closeout Working Group (1999 to
present)
Vice-Chair ASRM Menopause Special Interest Group (2003)
New York City Resolve: Medical Advisory Board, 1998-1999
American Infertility Association: Medical Advisory Board, 1999- 2000
Obstetrics and Gynecology
American Journal of Obstetrics and Gynecology
Fertility and Sterility
Editorial Board
Journal of Assisted Reproduction and Genetics
Journal of Fertilization In Vitro

NIH Funded Research
Co-Investigator- Women’s Health Initiative ..................................................................... 1994-Present
The Clinical Center of the Department of Obstetrics, Gynecology & Women’s Health of the
Montefiore Medical Center/ Albert Einstein College is one of 40 clinical centers selected to conduct
the WHI Clinical Trial and Observational Study and is the only one in the metropolitan New York
area. The Women’s Health Initiative (WHI) is a national, multicenter study of the health of
postmenopausal women and consists of several overlapping clinical trials to test interventions to
prevent breast cancer, heart disease and colorectal cancer and osteoporosis. The WHI also includes
an observational study to uncover disease markers and risk factors. The clinical trials are initiated to
determine if hormone replacement therapy (HRT) prevents heart disease, osteoporosis and colorectal
cancer. One ancillary study seeks to determine if HRT prevents Alzheimer's disease and ageassociated
cognitive decline. The Dietary Modification Trial seeks to determine if a low fat, high
grain, fruit and vegetable eating patterns will prevent breast cancer and heart disease. The
Calcium/Vitamin D supplement trial is to determine if these supplements will prevent osteoporosis
and colorectal cancer. The WHI is the largest clinical trial ever funded by NIH. Nationally, 160, 000
women are participating. The WHI represents a collaborative effort of the departments of
Epidemiology and Social Medicine, OBGYN-WH, and Medicine. The AECOM/ MMC Clinical
Center succeeded in recruiting the goal of 4,500 community-based women within the Bronx and NY
Metropolitan area.
CV David Barad Page 7

Invited presentations over past 5 years
1. Cryopreservation and risk for triplet pregnancy. Budapest, Hungary June 2002.
2. "WHI: Where We Are and Where We Are Going." June 18, 2002; Wave Hill, Bronx, NY
3. What we have learned: lessons from the Women’s Health Initiative, Grand Rounds September 16,
2003, CHR New York, NY
4. What we have learned: lessons from the Women’s Health Initiative, Grand Rounds September 26,
2003, CHR Chicago, Ill.
5. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women, Department of
Obstetrics and Gynecology, Salt Lake City, Utah March 26, 2003.
6. Is there still a place for surgery? Center for Human Reproduction; Post-Graduate Course. Chicago,
Illinois June 2003.
7. “Infertility for Beginners: Questions and Answers” American Infertility Association, Grand Hyatt, New
York, NY March 25, 2004.
8. Infertility treatment for the Primary Care Provider, Center for Human Reproduction, Postgraduate
course, June 2003.
9. WHI: Estrogen plus Progestin Breast and Gynecologic Cancer, Cornell Presbyterian Medical Center,
October 20, 2003.
10. Hormone treatment and Cardiovascular Disease: Are SERMs the Answer? Taiwan Society of
Cardiovascular Disease Prevention and Control. 9th Nov, 2003
11. New ideas in ovulation induction. Dept of Onstetrics and Gynecology NYU Downtown May 2005
12. What happened when the hormones stopped? : after the WHI. Englewood Hospital, Englewod, NJ
May 10 2005
13. Traditional Chinese Medicine and Hot Flashes. Presented to the TCM Society of New York, February
2005
14. Symptom experience after discontinuing use of estrogen plus progestin in the WHI Clinical trial.
Maimonides Medical Center, Brooklyn NY, January 6, 2006
15. Managing menopausal symptoms among minority women. Symposium, “Evidence based approaches to
Menopause III. SGI Toronto Canada March 24, 2006
16. Evidence based medicine (EBM): what’s next? Cannot replace clinical judgment. Controversies in
Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.
17. Preimplantation genetic screening (PGS) is an experimental tool that should be banned from routine
clinical use: PGS, as currently practiced, is associated with inferior results and should not be
routinely offered. Controversies in Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.
18. Has anti-Mullerian hormone (AMH) become essential in assessing ovarian reserve?: No.
Controversies in Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.
19. Can diminished ovarian reserve be treated effectively?: Yes. Controversies in Obstetrics and
Gynecology. Berlin, Germany, November 4-6, 2010.
CV David Barad Page 8

Medical School Committees: ..................................................................................
Ethics Committee on Reproductive Technology -1987 - 2000
Admissions Committee of Albert Einstein College of Medicine - 1988 – 1993
Subcommittee on Clinical Sciences Curriculum -1986- 1988
Educational Planning and Policy Committee - 1986 - 1990
Department of Obstetrics and Gynecology Promotions Committee: 1992- 1998
Dean's Committee on Conflict of Interest: 1994-1996
CV David Barad Page 9

Bibliography
A. Original Communications in Reviewed Journals: (1-54)
[1-50]
1. Callard, I.P., V. Lance, A.R. Salhanick, and D. Barad. The annual ovarian cycle of Chrysemys
picta: correlated changes in plasma steroids and parameters of vitellogenesis. Gen Comp
Endocrinol, 1978. 35(3): p. 245-57.
2. Barad, D.H., M.L. Gimovsky, R.H. Petrie, and E.T. Bowe. Diagnosis and management of
bilateral theca lutein cysts in a normal term pregnancy. Diagn Gynecol Obstet, 1981. 3(1): p. 27-
30.
3. Baxi, L., E.A. Reece, and D. Barad. Hemoglobin A1c levels and variant hemoglobins. Am J
Obstet Gynecol, 1984. 150(6): p. 794-5.
4. Baxi, L., D. Barad, E.A. Reece, and R. Farber. Use of glycosylated hemoglobin as a screen for
macrosomia in gestational diabetes. Obstet Gynecol, 1984. 64(3): p. 347-50.
5. Baxi, L., E.A. Reece, D. Barad, R. Farber, and A. Williams. Glycosylated hemoglobin (HbA1)
and hemoglobinopathies in pregnancy. J Perinat Med, 1984. 12(3): p. 133-6.
6. Schneider, E.P., H.E. Fox, D. Barad, and R.S. Farber. Fluorescence polarization values of
amniotic fluid collected from the vagina after rupture of the membranes. Am J Obstet Gynecol,
1985. 152(5): p. 572-3.
7. Barad, D.H., G. Bartfai, P. Barg, B.L. Cohen, and M. Feinman. Gamete intrafallopian tube
transfer (GIFT): making laparoscopy more than "diagnostic". Fertil Steril, 1988. 50(6): p. 928-30.
8. Barad, D.H., K.J. Ryan, K. Elkind-Hirsch, and A. Makris. Immunoreactive substance P in the
human ovary. Am J Obstet Gynecol, 1988. 159(1): p. 242-6.
9. Barad, D. and M. Feinman. GnRH Agonists and IVF--controls? Fertil Steril, 1989. 52(3): p. 518-
9.
10. Feinman, M., D. Barad, I. Szigetvari, and S.G. Kaali. Availability of donated oocytes from an
ambulatory sterilization program. J Reprod Med, 1989. 34(7): p. 441-3.
11. Szigetvari, I., M. Feinman, D. Barad, G. Bartfai, and S.G. Kaali. Association of previous
abdominal surgery and significant adhesions in laparoscopic sterilization patients. J Reprod Med,
1989. 34(7): p. 465-6.
12. Barg, P.E., D.H. Barad, and W. Feichtinger. Ultrarapid freezing (URF) of mouse and human
preembryos: a modified approach. J In Vitro Fert Embryo Transf, 1990. 7(6): p. 355-7.
13. Borgatta, L., L. Gruss, D. Barad, and S.G. Kaali. Direct trocar insertion vs. Verres needle use for
laparoscopic sterilization. J Reprod Med, 1990. 35(9): p. 891-4.
CV David Barad Page 10

14. Feichtinger, W., D. Barad, M. Feinman, and P. Barg. The use of two-component fibrin sealant for
embryo transfer. Fertil Steril, 1990. 54(4): p. 733-4.
15. Kaali, S.G., G.M. Csakany, I. Szigetvari, and D.H. Barad. Updated screening protocol for
abortion services. Obstet Gynecol, 1990. 76(1): p. 136-8.
16. Barad, D.H. Infertility surgery by laparotomy. Curr Opin Obstet Gynecol, 1991. 3(3): p. 398-403.
17. Borgatta, L. and D. Barad. Prolonged retention of laminaria fragments: an unusual complication
of laminaria usage. Obstet Gynecol, 1991. 78(5 Pt 2): p. 988-90.
18. Borgatta, L., L. Gruss, and D. Barad. Randomized trial of local anesthetic application for the
relief of postoperative pain after tubal sterilization with Fallope rings. Am J Gynecol Health,
1991. 5: p. 11-15.
19. Daiter, E., S. Pampfer, Y.G. Yeung, D. Barad, E.R. Stanley, and J.W. Pollard. Expression of
colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab, 1992.
74(4): p. 850-8.
20. Kaali, S.G. and D.H. Barad. Incidence of bowel injury due to dense adhesions at the sight of
direct trocar insertion. J Reprod Med, 1992. 37(7): p. 617-8.
21. Naz, R.K., D. Barad, P. Barg, K. Ahmad, and K. Bhargava. Antigenic differences in human
sperm samples related to various morphological abnormalities. Arch Androl, 1992. 29(2): p. 117-
26.
22. Pampfer, S., E. Daiter, D. Barad, and J.W. Pollard. Expression of the colony-stimulating factor-1
receptor (c-fms proto-oncogene product) in the human uterus and placenta. Biol Reprod, 1992.
46(1): p. 48-57.
23. Witt, B.R. and D.H. Barad. Management of endometriosis in women older than 40 years of age.
Obstet Gynecol Clin North Am. Vol. 20. 1993. 349-63.
24. Kaali, S.G., D.H. Barad, and I.R. Merkatz. Comparison of visual and tactile localization of the
trocar tip during abdominal entry. J Am Assoc Gynecol Laparosc, 1994. 2(1): p. 75-7.
25. Kaali, S.G. and D.H. Barad. An updated protocol for abortion surveillance with ultrasound and
immediate pathology. Obstet Gynecol, 1994. 83(5 Pt 1): p. 797-8.
26. LindHeim, S.R., R. Freeman, B. Witt, and D.H. Barad. The Possible Attenuating Effects of
Estrogen on Circadian Blood Pressure Variation Using 24 Hour Ambulatory Monitoring. Journal
of the Society for Gynecologic Investigation, 1995. 2(2): p. 428.
27. Naz, R.K., A. Butler, B.R. Witt, D. Barad, and A.C. Menge. Levels of interferon-gamma and
tumor necrosis factor-alpha in sera and cervical mucus of fertile and infertile women: implication
in infertility. J Reprod Immunol, 1995. 29(2): p. 105-17.
28. Palan, P.R., B.L. Cohen, D.H. Barad, and S.L. Romney. Effects of smoking on the levels of
antioxidant beta carotene, alpha tocopherol and retinol in human ovarian follicular fluid. Gynecol
CV David Barad Page 11

Obstet Invest, 1995. 39(1): p. 43-6.
29. Witt, B.R., D.H. Barad, P. Barg, B.L. Cohen, S.R. Lindheim, L. Testaiuti, and H.K. Amin. Basal
serum follicle stimulating hormone (FSH) and estradiol levels as predictors of pregnancy in
unstimulated donor insemination cycles. J Assist Reprod Genet, 1995. 12(3): p. 157-60.
30. Fisch, H., E.T. Goluboff, J.H. Olson, J. Feldshuh, S.J. Broder, and D.H. Barad. Semen analyses in
1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril, 1996.
65(5): p. 1009-14.
31. Kaali, S.G., D.H. Barad, and I.R. Merkatz. Avoiding trocar injuries--is there a fail-safe
method?[comment]. Fertility & Sterility, 1996. 66(6): p. 1045-6.
32. Lindheim, S.R., D.H. Barad, B. Witt, E. Ditkoff, and M.V. Sauer. Short-term gonadotropin
suppression with oral contraceptives benefits poor responders prior to controlled ovarian
hyperstimulation. J Assist Reprod Genet, 1996. 13(9): p. 745-7.
33. Lindheim, S.R., D.H. Barad, M. Zinger, B. Witt, H. Amin, B. Cohen, H. Fisch, and P. Barg.
Abnormal sperm morphology is highly predictive of pregnancy outcome during controlled
ovarian hyperstimulation and intrauterine insemination. J Assist Reprod Genet, 1996. 13(7): p.
569-72.
34. Mukherjee, T., D. Barad, R. Turk, and R. Freeman. A randomized, placebo-controlled study on
the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated
with six months of gonadotropin-releasing hormone agonist treatment. Am J Obstet Gynecol,
1996. 175(1): p. 105-9.
35. Borgatta, L., R.W. Jenny, L. Gruss, C. Ong, and D. Barad. Clinical significance of methohexital,
meperidine, and diazepam in breast milk. J Clin Pharmacol, 1997. 37(3): p. 186-92.
36. Kaali, S.G., D.H. Barad, and I.R. Merkatz. Modified open laparoscopy through placement of an
optical surgical obturator. Fertil Steril, 1997. 67(5): p. 969-71.
37. Kaali, S.G. and D.H. Barad. Direct laparoscopic entry using a sharp and dull trocar technique.
Obstet Gynecol, 1997. 89(1): p. 156-7.
38. Johnson, S.R., G.L. Anderson, D. Barad, and M.L. Stefanick. The Women's Health Initiative:
rationale, design and progress report. J Brit Menopause Soc, 1999. 5: p. 155-159.
39. Barad, D.H. and B.R. Witt. Multiple pregnancies and assisted reproductive technologies. J
Womens Health Gend Based Med, 2000. 9(2): p. 101-7.
40. Bevilacqua, K., D. Barad, J. Youchah, and B. Witt. Is affect associated with infertility treatment
outcome? Fertil Steril, 2000. 73(3): p. 648-9.
41. Anderson, G.L., H.L. Judd, A.M. Kaunitz, D.H. Barad, S.A. Beresford, M. Pettinger, J. Liu, S.G.
McNeeley, and A.M. Lopez. Effects of estrogen plus progestin on gynecologic cancers and
associated diagnostic procedures: the Women's Health Initiative randomized trial. Jama, 2003.
290(13): p. 1739-48.
CV David Barad Page 12

42. Chen, Z., M.B. Pettinger, C. Ritenbaugh, A.Z. LaCroix, J. Robbins, B.J. Caan, D.H. Barad, and
I.A. Hakim. Habitual tea consumption and risk of osteoporosis: a prospective study in the
women's health initiative observational cohort. Am J Epidemiol, 2003. 158(8): p. 772-81.
43. Hsia, J., D. Barad, K. Margolis, R. Rodabough, P.G. McGovern, M.C. Limacher, A. Oberman,
and S. Smoller. Usefulness of prior hysterectomy as an independent predictor of Framingham risk
score (The Women's Health Initiative). Am J Cardiol, 2003. 92(3): p. 264-9.
44. Santoro, N., B. Isaac, G. Neal-Perry, T. Adel, L. Weingart, A. Nussbaum, S. Thakur, H. Jinnai, N.
Khosla, and D. Barad. Impaired folliculogenesis and ovulation in older reproductive aged women.
J Clin Endocrinol Metab, 2003. 88(11): p. 5502-9.
45. Stefanick, M.L., B.B. Cochrane, J. Hsia, D.H. Barad, J.H. Liu, and S.R. Johnson. The Women's
Health Initiative postmenopausal hormone trials: overview and baseline characteristics of
participants. Ann Epidemiol, 2003. 13(9 Suppl): p. S78-86.
46. Lee, I., P.T. Finger, J.A. Grifo, A.R. Rausen, A. Rebarber, and D.H. Barad. Retinoblastoma in a
child conceived by in vitro fertilisation. Br J Ophthalmol, 2004. 88(8): p. 1098-9.
47. Pal, L., P. Kovacs, B. Witt, S. Jindal, N. Santoro, and D. Barad. Postthaw blastomere survival is
predictive of the success of frozen-thawed embryo transfer cycles. Fertil Steril, 2004. 82(4): p.
821-6.
49. Barad, D. and N. Gleicher. Increased oocyte production after treatment with
dehydroepiandrosterone. Fertil Steril. 2005 Sep; 84(3):756.
50. Chen, Z., M. Maricic, T.L. Bassford, M. Pettinger, C. Ritenbaugh, A.M. Lopez, D.H. Barad, M.
Gass, and M.S. Leboff. Fracture Risk Among Breast Cancer Survivors: Results From the
Women's Health Initiative Observational Study. Arch Intern Med, 2005. 165(5): p. 552-8.
51. Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB. Prior oral
contraception and postmenopausal fracture: a Women's Health Initiative observational cohort
study. Fertil Steril 2005;84(2):374-83.
52. Chen, Z., M. Maricic, M. Pettinger, C. Ritenbaugh, A.M. Lopez, D.H. Barad, M. Gass, M.S.
Leboff, and T.L. Bassford, Osteoporosis and rate of bone loss among postmenopausal survivors
of breast cancer. Cancer, 2005.
53. Ockene, J.K., D.H. Barad, B.B. Cochrane, J.C. Larson, M. Gass, S. Wassertheil-Smoller, J.E.
Manson, V.M. Barnabei, D.S. Lane, R.G. Brzyski, M.C. Rosal, J. Wylie-Rosett, and J. Hays,
Symptom experience after discontinuing use of estrogen plus progestin. JAMA, 2005. 294(2): p.
183-93.
54. Prentice, R.L., R. Langer, M.L. Stefanick, B.V. Howard, M. Pettinger, G. Anderson, D. Barad,
J.D. Curb, J. Kotchen, L. Kuller, M. Limacher, and J. Wactawski-Wende, Combined
Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the
Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial. Am
J Epidemiol, 2005. 162(5): p. 404-14.
CV David Barad Page 13

55. Rebecca D. Jackson, M.D., Andrea Z. LaCroix, Ph.D., Margery Gass, M.D., Robert B. Wallace,
M.D., John Robbins, M.D., Cora E. Lewis, M.D., Tamsen Bassford, M.D., Shirley A.A.
Beresford, Ph.D., Henry R. Black, M.D., Patricia Blanchette, M.D., Denise E. Bonds, M.D.,
Robert L. Brunner, Ph.D., Robert G. Brzyski, M.D., Bette Caan, Dr.P.H., Jane A. Cauley,
Dr.P.H., Rowan T. Chlebowski, M.D., Steven R. Cummings, M.D., Iris Granek, M.D., Jennifer
Hays, Ph.D., Gerardo Heiss, M.D., Susan L. Hendrix, D.O., Barbara V. Howard, Ph.D., Judith
Hsia, M.D., F. Allan Hubbell, M.D., Karen C. Johnson, M.D., Howard Judd, M.D., Jane Morley
Kotchen, M.D., Lewis H. Kuller, M.D., Robert D. Langer, M.D., Norman L. Lasser, M.D.,
Marian C. Limacher, M.D., Shari Ludlam, M.P.H., JoAnn E. Manson, M.D., Karen L. Margolis,
M.D., Joan McGowan, Ph.D., Judith K. Ockene, Ph.D., Mary Jo O'Sullivan, M.D., Lawrence
Phillips, M.D., Ross L. Prentice, Ph.D., Gloria E. Sarto, M.D., Marcia L. Stefanick, Ph.D., Linda
Van Horn, Ph.D., Jean Wactawski-Wende, Ph.D., Evelyn Whitlock, M.D., Garnet L. Anderson,
Ph.D., Annlouise R. Assaf, Ph.D., David Barad, M.D., for the Women's Health Initiative
Investigators. Calcium plus Vitamin D Supplementation and the Risk of Fractures. New England
Journal of Medicine, 2006, Volume 354:669-683.
56. Gleicher, N.G. Barad, D. An evolutionary concept of polycystic ovarian disease: does evolution
favour reproductive success over survival? RBMOnline, 2006. vol 12.
57. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation
among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629-34.
58. Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone
assessment of ovarian function. Obstet Gynecol 2007;109:1404-10.
59. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around
individual BDNF gene promoters in prefrontal cortex are associated with extinction of
conditioned fear. Learn Mem 2007;14:268-76.
60. Gleicher N, Barad D. DHEA and testosterone in the elderly. N Engl J Med 2007;356:636-7;
author reply 7.
61. Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity?
Autoimmun Rev 2007;7:42-5.
70. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007;28:1-
6.
62. Gleicher N, Barad DH. Mild versus standard in-vitro fertilisation techniques. Lancet
2007;369:1855; author reply -6.
63. Gleicher N, Barad DH. The choice of gender: is elective gender selection, indeed, sexist? Hum
Reprod 2007.
64. Gleicher N, Weghofer A, Barad D. Update on the comparison of assisted reproduction outcomes
between Europe and the USA: the 2002 data. Fertil Steril 2007;87:1301-5.
65. Gleicher N, Weghofer A, Barad D. Too old for IVF: are we discriminating against older women?
J Assist Reprod Genet 2007;24:639-44.
CV David Barad Page 14

66. Gleicher N, Weghofer A, Barad D. On the benefit of assisted reproduction techniques, a
comparison of the USA and Europe. Hum Reprod 2007;22:624-6.
67. Gleicher N, Weghofer A, Li J, Barad D. Differences in ovarian function parameters between
Chinese and Caucasian oocyte donors: do they offer an explanation for lower IVF pregnancy
rates in Chinese women? Hum Reprod 2007;22:2879-82.
68. Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S et al. Association of pelvic
organ prolapse and fractures in postmenopausal women: analysis of baseline data from the
Women's Health Initiative Estrogen Plus Progestin trial. Menopause 2007;Publish Ahead of Print.
69. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM et al. Postmenopausal
hormone therapy and risk of cardiovascular disease by age and years since menopause. Jama
2007;297:1465-77.
70. Weghofer A, Barad D, Li J, Gleicher N. Aneuploidy rates in embryos from women with
prematurely declining ovarian function: a pilot study. Fertil Steril 2007;88:90-4.
71. Weghofer A, Munne S, Chen S, Barad D, Gleicher N. Lack of association between polycystic
ovary syndrome and embryonic aneuploidy. Fertil Steril 2007.
72. Weghofer A, Schnepf S, Barad D, Gleicher N. The impact of luteinizing hormone in assisted
reproduction: a review. Curr Opin Obstet Gynecol 2007;19:253-7.
73. Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S et al. Association of pelvic
organ prolapse and fractures in postmenopausal women: analysis of baseline data from the
Women's Health Initiative Estrogen Plus Progestin trial. Menopause 2008;15:59-66.
74. Weghofer A, Munne S, Brannath W, Chen S, Tomkin G, Cekleniak N et al. The impact of LHcontaining
gonadotropins on diploidy rates in preimplantation embryos: long protocol
stimulation. Hum Reprod 2008;23:499-503.
75. Gleicher N, Weghofer A, Oktay K, Barad D: Is the immunological noise of abnormal
autoimmunity an independent risk factor for premature ovarian aging? Menopause.
2009;16(4):760-4.
76. Gleicher N, Weghofer A, Oktay K, Barad D: Can the FMR1 (fragile X) gene serve as predictor of
response to ovarian stimulation? Reprod Sci. 2009;5: 462-7.
77. Gleicher N, Weghofer A and Barad D. Age-specific ovarian function. Expert Rev Obstet
Gynecol. 2008;3(5): 595-600.
78. Gleicher N, Weghofer A, Oktay K, Barad D: Relevance of low triple CGG repeats on the FMR1
gene to ovarian reserve: Is there a normal range? RBMOnline. 2008;19(3):385-90.
79. Barad D, Weghofer A, Gleicher N: Comparing anti-Mullerian hormone (AMH) and folliclestimulationg
hormone (FSH) as predictors of ovarian function. Fertil Steril 2009;91(supl 4):1553-
5.
CV David Barad Page 15

80. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile
X) gene to ovarian reserve: A new infertility test? Acta Obstetrica et Gynecologica Scandinavica.
2009; 88(9):1024-30.
81. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene
to ovarian reserve. RBMOnline 2009:3:385-390.
82. Gleicher N and Barad D.: Patients are entitled to maximal IVF pregnancy rates. Reprod Biomed
Online 2009;18:599-602.
83. Gleicher N, Barad D et al..: Can the FMR1 (fragil X) gene serve as predictor of response to
ovarian stimulation? Reprod Sci 2009;16:462-7.
84. Gleicher N, Weghofer A, Oktay K, Barad D.: Do etiologies of premature ovarian aging (POA)
mimic those of premature ovarian failure (POF)? Hum Reprod 2009;24:2395-400.
85. Gleicher N et al.: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in
women with diminished ovarian reserve: a case control study. Reprod Biol Endocrionol
2009:7;108.
86. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P and Gleicher N: Can
prematurity risk in twin pregnancies after in vitro fertilization be predicted? A retrospective
study. Reprod Biol Endocrionol 2009;7:136.
87. Weghofer A, Klein K, Stammler-Safar M, Barad DH, Worda C, Husslein P and Gleicher N.
Severity of prematurity risk in spontaneous and in vitro fertilization twins: does conception mode
serve as a risk factor? Fertil Steril 2009:92(6):2116-2118.
88. Gleicher N, Barad D. “Patient-friendly” IVF. Expert Rev Obstet Gynecol 2010:5(1);1-4.
89. Gleicher N, Barad D. Can the FMR1 gene predict early ovarian aging? Women’s Health
2010:6(2);165-9.
90. Barad DH, Weghofer A, Goyal A, Gleicher N. Utility of age-specific anti-Mullerian hormone
concentrations. RBMOnline 2011;22:284-91.
91. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of
FMR1 (fragile X gene) in regulating ovarian aging. RBMOnline 2010;20(6):768-775.
92. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P, Gleicher N. The
impact of fetal gender on prematurity in dichorial twin gestations after in vitro fertilization.
Reprod Bio Endocrin 2010,8:57.
93. Gleicher N, Barad DH. Further comments on the Suleman case. Expert Rev Obstet Gynecol
2010;5(5):501-2.
94. Gleicher N, Barad DH. Misplaced obsession with prospectively randomized studies. RBMOnline
2010;21(4): 440-443.
CV David Barad Page 16

95. Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH)
and anti-Mullerian hormone (AMH) in female infertility. Reprod Biol Endocrionol 2010;8:64.
96. Gleicher N, Weghofer A, Barad DH. Can egg donor selection be improved? A pilot study.
Reprod Biol Endocrinol 2010;8:76.
97. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1
gene in infertile women and egg donors. RBMOnline 2010;20:485-491.
98. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after
dehydroepiandrosterone supplementation. RBMOnline 2010;21:360-365.
99. Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve.
Obstetrical and Gynecological Survey 2010. In Press.
100. Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo
aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol
Endocrinol 2010;8:140.
101. Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunity-associated
polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One 2010 Dec
16;5(12):e15303.
102. Gleicher N, Weghofer A, Barad DH. Does chromosomally abnormal pregnancies really preclude
autoimmune etiologies of spontaneous miscarriages? Autoimmunity Rev 2010. [Epub ahead of
print.]
103. Gleicher N, Weghofer A, Barad DH. Successful treatment of unresponsive thin endometrium.
Fertil Steril 2011, In pRess.
104. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging.
Repord Biol Endocrinol 2011 [Epub ahead of print].
105. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro
fertilization (IVF) outcomes based on ethnicity/race. PLoS One 2011;6(4):e18781.
106. Gleicher N, Barad DH. Gestational dermatosis shortly after implantation associated with parental
class II HLA compatibility and maternal immune activation: preliminary report of a prospective
case series. Dermatology 2011; DOI10.1159/000327377.
107. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian
reserve (DOR). Reprod Biol Endocrinol 2011;9:67.
108. Gleicher N, Weghofer A, Barad DH. Cutting edge assessment of the impact of autoimmunity on
female reproductive success. J Autoimmunity 2011, In Press.
109. Weghofer A, Dietrich W, Ortner I, Bieglmayer C, Barad D, Gleicher N. Anti-Mullerian hormone
levels decline under hormonal suppression: a prospective analysis in fertile women after delivery.
Reprod Biol Endocrinol 2011;9(1):98.
CV David Barad Page 17

Books:(1-14)
110. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation
induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9(1):116.
111. Gleicher N, Kim A, Weghofer A, Barad DH. Towards a better understanding of functional
ovarian reserve: AMH (AMHo) and FSH (FSHo), hormone ratios per retrieved oocyte. J Clin
Endocrinol Metab 2011; In Press.
112. Gleicher N, Weghofer A, Barad DH. A case-control pilot study of low intensity in vitro
fertilization (LI-IVF) in good prognosis patients. Reprod Biomed Online 2011; In Press.
113. Gass ML et al. Patterns and predictors of sexual activity among women in the Hormone Therapy
trials of the Women's Health Initiative. Menopause 2011;18(11):1160-71.
114. Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian FMR1
genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012;3(7):e33638.
115. Gleicher N, Weghofer A, Kim A, Barad DH. Comparison of ovarian FMR1 genotypes and subgenotypes
in oocyte donros and infertile women. J Assist Reprod Genet 2012; In Press.
116. Gleicher N and Barad DH. "Hype" or "hope": Ethical and practical considerations in association
with clinical research in women with diminished ovarian reserve. Reprod Biomed Online 2012;
In Press.
B. Books, Chapters in Books, and Review Articles
1. Barad D. In Vitro Fertilization. In: Martini L, ed. Encyclopedia of Endocrine Diseases.
Amsterdam Boston; 2004:Elsevier Academic Press.
2. Barad D, Schiff I. Hirsutism and Virilism. In: Hare JW, ed. Signs and Symptoms of Endocrine
and Metabolic Disorder. London Mexico New York: J.B. Lippincott Co; 1986:68.
3. Schneider E, Fox H, Barad D, Farber R. Fluorescence polarization values of amniotic fluid
collected from the vagina after rupture of membranes. In: Yearbook of Pathology and Clinical
Pathology; 1987.
4. Barad D. Work-up of the Infertile Couple. In: Barad D, ed. Infertility and Reproductive Medicine
Clinics of North America. Philadelphia London Toronto Montreal Tokoyo: WB Saunders
Company; 1991:WB Saunders Company.
5. Barad D. Epidemiology of Infertility. In: Barad D, ed. Workup of the Infertile Woman.
Philadelphia London Toronto Montreal Tokoyo: WB Saunders Company; 1991:255.
6. Kaali S, Bartfai G, Feinman M, Barad D. Battery-operated birth control devices based on the
effect of low electrical current on sperm motility. In: Female contraception and male fertility
regulation. Carnforth, Lancs, UK ; Park Ridge, N.J., USA: Parthenon Publishing Group;
1991:165.
CV David Barad Page 18

7. Mednick R, Mednick E, Ratz O, Barad D. Adoption: To have a family, not just a pregnancy. In:
Barad D, ed. Workup of the Infertile Woman. Philadelphia London Toronto Montreal Tokoyo:
WB Saunders Company; 1991.
8. Testaiuti L, Barad D. Office Management of Couples with Impaired Fertility. In: Barad D, ed.
Workup of the Infertile Woman. Philadelphia London Toronto Montreal Tokoyo: WB Saunders
Company; 1991.
9. Pollard J, Pampfer S, Daiter E, Barad D, Areci R. Colony-stimulating factor I in the mouse and
human uteroplacental unit. In: Schomberg D, ed. Growth factors in reproduction. New York:
Springer-Verlag; 1991.
10. Barad D, ed. Perimenopausal Health Care. Philadelphia: WB Saunders Company; 1993.
11. Witt B, Barad D. Management of endometriosis in women over forty years of age. In: Barad D,
ed. Perimenopausal Health Care. Philadelphia London Toronto Montreal Tokoyo: WB Saunders
Company; 1993:349.
12. Barad D, Cohen B. Oocyte Donation Program at Montefiore Medical Center, Albert Einstein
College of Medicine, Bronx, New York. In: Cohen CB, ed. New ways of Making Babies: the case
of egg donation. Bloomington, Ind: Indiana University Press; 1996:15.
13. Barad D. Turners Syndrome. In: Knobil E, Neill J, eds. Encyclopedia of Reproduction.
Burlington London San Diego: Academic Press; 1999.
14. Charney P, Boynton U, Barad D, Polansky M. The Pelvic Examination. In: Ryden J, Blumenthal
P, eds. Practical Gynecology - A Guide for the Primary Care Physician. Philadelphia;
2002:American College of Physicians.
15. Barad, DH. Approach to the Gynecological Patient. In: The Merck Manual. 18 th Edition. Merck
Research Lboratories, Whithouse Station. NJ. 2006.
16. Gleicher N, Barad DH. Dehydroepiandrosterone. In: Kovacs G ed. How to improve your ART
success rates: An evidence-based review of adjuncts to IVF. Cambridge University Press,
London, UK. 2011.
C. Abstracts: (1-73)
1. Baxi L, Reece E, Barad D, Farber R, Williams A. Glycosylated hemoglobin and
hemoglobinopathies in pregnancy In: 29th Annual Meeting of the Society for Gynecologic
Investigion 1982 March 24-27, 1982; Dallas, Tx; 1982.
2. Baxi L, Barad D, Reece E, Farber R. Significance of glycosylated hemoglobin in class A diabetes
in pregnancy In: 29th Annual Meeting of the Society for Gynecologic Investigion 1982 March
CV David Barad Page 19

24-27, 1982; Dallas, Tx; 1982.
3. Barad D, Kaali S, Bartfai G, Feinman M. Hysteroscopic location of "lost IUD" during firsttrimester
pregnancy In: AAGL 16th Annual Meeting 1987 Nov 10-15, 1987; San Francisco, CA
1987.
4. Bartfai G, Feinman M, Barad D, Kaali S. Long-Term Follow-up of Laparoscopic Female
Sterilization In: AAGL 16th Annual Meeting 1987 Nov 10 -15, 1987 San Francisco, CA 1987.
5. Feinman M, Barad D, Bartfai G, Kaali S, Merkatz I. The true incidence of uterine perforation
during laparoscopic sterilization In: Second World Congress of Endoscopic Female Sterilization
1987 July 9-12, 1987; Colonial Williamsburg, VA 1987.
6. Feinman M, Bartfai G, Kaali S, Barad D, Merkatz I. Treatment Independent Pregnancies After In
Vitro Fertilization and Embryo Transfer In: Vth World Congress IVF-ET; 1987 April 27-30 (AP-
663) Norfolk, VA 1987.
7. Kaali S, Bartfai G, Barad D, Feinman M, Merkatz I. Direct Insertion of the Laparoscopic Trocar
in Patients with Previous Abdominal Surgery In: ACOG 35th Meeting 1987 April 27-30, 1987
Las Vegas, NV 1987.
8. Kaali S, Barad D, Bartfai G, Feinman M, Merkatz I. Safely Conducted Laparoscopic Sterilization
in Women with Previous Umbilical Hernia Repairs In: Second World Congress of Endoscopic
Female Sterilization 1987 July 9-12, 1987 Colonial Williamsburg, VA 1987.
9. Kaali S, Bartfai G, Feinman M, Barad D. Outpatient Laparoscopy for Obese Women with
Previous Abdominal Surgery In: AAGL Annual Meeting 1987 Nov 10 -15, 1987 San Francisco,
CA 1987.
10. Palan P, Cohen B, Feinman M, Barad D, Mikhail M, Basu J, Romney S. B-Carotene and Vitamin
A in Human Ovarian Follicular Fluid In: Presented at Society for Gynecologic Investigation;
1987 March 15-19, 1989; San Diego, CA; 1987.
11. Barad D. Availability of Oocytes for Donation from an Ambulatory Sterilization Program In:
AAGL 17th Annual Meeting 1988 November 9-13 1988 Dallas, TX 1988.
12. Feinman M, Barad D, Barg P, Cohen B. The effect of tubal pathology on pregnancy rates
following gamete intrafallopian tube transfer In: Society for Gynecologic Investigion 1988 Oct 3-
8, 1988 Atlanta, Georgia 1988.
13. Barad D, Freeman R, Speranza M, Damiano A, Feinman M. Effect pf dietary fat on absorption of
micronized estradiol In: Endocrine Society 71st Annual Meeting 1989 June 1989 Seattle, WA
1989.
14. Barad D, Feinman M, Gruss L, Borgatta L, Kaali S. Outpatient management of ectopic pregnancy
In: 18th Annual World Congress of Gynecological Endoscopy AAGL 1989 Sept. 20-24, 1989;
Washington D.C. ; 1989.
15. Barg P, Feinman M, Barad D, Feichtinger W. Ultra-Rapid Freezing of Mouse Embryos In:
CV David Barad Page 20

Presented at the VI World Congress In Vitro Fertilization and Alternate Assisted Reproduction;
1989 April 2-7, 1989; Jerusalem, Israel; 1989.
16. Borgatta L, Gruss L, Barad D, Kaali S. Direct trocar insertion versus Verres needle use for
laparoscopic tubal sterilization In: ACOG 37 Meeting 1989 1989 Atlanta 1989 1989.
17. DH B, W F. Ovarian and uterine blood flow by transvaginal Doppler ultrasound suring ovulation
induction. In: Syllabus Endovaginal Sonography; 1989; 1989.
18. Feinman M, Barad D, Hailparn T, Cohen B, Barg P, Freeman R. The Use of Parenteral Estradiol
Valerate in a Donor Oocyte Program In: VI World Congress In Vitro Fertilizion and Alterne
Assisted Reproduction 1989 April 2-7, 1989; Jerusalem, Israel, ; 1989.
19. Feinman M, Barad D, Cohen B, Barg P, Ratz O. The value of (Gamete intrafallopian tube
transfer) GIFT for women over forty In: 18th Annual World Congress of Gynecological
Endoscopy AAGL 1989 Sept. 20-24, 1989; Washington D.C. ; 1989.
20. Freeman R, Duvivier R, Barad D, Weller R. The effect of depot medroxyprogesterone acetate on
cholesterol,lipoprotein cholesterol and triglicerides in postmenopausal women In: New York
Academy of Sciences - North american Menopause Society 1989 Sept 21 - 23, 1989; New York,
NY; 1989.
21. Gruss L, Barad D, Borgatta L, Kaali S. Management of unsuspected ectopic pregnancy at the
time of sterilization in an ambulatory surgery center In: 18th Annual World Congress of
Gynecological Endoscopy AAGL 1989 Sept. 20-24, 1989; Washington D.C. ; 1989.
22. Kaali S, Barad, DH, Bartfai, G Laparoscopic recovery of fetal calvarium at midtrimester abortion
In: 2nd World Congress of Gynecologic Endoscopy Clermont-Ferrand 1989 June 5-7, 1989 Paris,
France 1989.
23. Szigetvari I, Feinman M, Barad D, Bartfai G, Kaali S. The Association of previous abdominal
surgery and adhesions in laparoscopic sterilization patients In: 17th Annual Meeting First North
American/South American Congress of Gynecologie Endoscopy 1989 November 9-13 1989
Dallas, TX 1989.
24. Barad D, Feinman M, Cohen B, Unfried E, Feichtinger W. Radioactive cesium in follicular fluid
and reproductive performance In: Society for Gynecological Investigion 1990 March 21-24, 1990
St Louis, Mo 1990.
25. Barad D, Feinman M, Kaali S. Outpatient management of ectopic pregnancy In: VII World
Congress on Human Reproduction 1990 June 1990 Helsinki - Finland 1990.
26. Barad D, Jaffe S, Kalli S, Merkatz I. Predictive vale of reproductive factors for pelvic/abdominal
adhesions In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki - Finland
1990.
27. Barad D, Barg P, Feinman M, Feichtinger W. The effect of a two component fibrin sealant on
mouse embryo culture In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki
- Finland 1990.
CV David Barad Page 21

28. Barad D, Feinman M. A comparison of treatment with danazol, GnRH agonist, or no treatment
prior to laparoscopic treatment of endometriomas In: AAGL 19th Annual Meeting 1990 Nov 14-
18,1990 Orlando, Florida 1990.
29. Borgatta L, Gruss L, Barad D. Effect of local application of bupivicaine on discomfort after tubal
sterilization with falope rings In: Associion of Reproductive Health Professionals 1990 1990;
1990.
30. Borgatta L, Barad D. Prolonged retention of laminaria fragments In: Associion of Reproductive
Health Professionals 1990 1990; 1990.
31. Cohen B, Feinman M, Barad D. Ovulation induction for in vitro fertilization using a programmed
stimulation protocol. In: American Fertility Society 46th Annual Meeting; 1990 October 15-18;
Washington, D.C.; 1990.
32. Daiter E, Pampfer S, Barad D, Pollard J. Temporal expression and location of colony stimulating
factor-1 (CSF-1) in the human female reproductive tract. In: American Fertility Society 46th
Annual Meeting; 1990 October 15-18; Washington, D.C.; 1990.
33. Feichtinger W, Kemeter P, Herczag K, Barad D. Ovarian and uterine blood flow by transvaginal
Doppler ultrasound during ovulation induction In: European Society of Reproductive
Endocrinology 1990 July 1990; 1990.
34. Feinman M, Pesce R, Olah J, Barad D. A simplified approach to monitoring early pregnancies In:
AAGL 19th Annual Meeting 1990 Nov 14 - 18 , 1990 Orlando, Florida 1990.
35. Freeman R, Small M, Thornhill B, Barad D. The effect of smoking on bone density in women
with premature ovarian failure vs normal women. In: American Fertility Society 46th Annual
Meeting; 1990 October 15-18; Washington, D.C.; 1990.
36. Kaali S, Bartfai G, Feinman M, Barad D. Utilizing the effect of low electrical current to improve
the efficacy of existing barrier birth control devices In: VII World Congress on Human
Reproduction 1990 June 1990 Helsinki - Finland 1990.
37. Kaali S, Csakany G, Szigetvari I, Feinman M, Barad D. A two visit protocol for screening ectopic
pregnancies in low risk populations In: VII World Congress on Human Reproduction 1990 June
1990 Helsinki - Finland 1990.
38. Kaali S, Bartfai G, Szigetari I, Csankany G, Olah J, Barad D, Feinman M. Fifteen year experience
with outpatient laparoscopic sterilization in a free standing facility In: AAGL 19th Annual
Meeting 1990 Nov 14 - 18 , 1990; Florida 1990.
39. Klugman S, Barad D. Continuation of intrauterine pregnancy after laparoscopic treatment of a
heterotopic ectopic pregnancy under local anesthesia In: AAGL 19th Annual Meeting 1990 Nov
14 - 18 , 1990 Orlando, Florida 1990.
40. Bar-Chama N, Fisch H, Barg P, Cohen B, Barad D. The use of flow cytometry for the
characterization and quantitation of seminal leukocytes In: American Fertility Society 1991
October 1991 1991.
CV David Barad Page 22

41. Barad D, Barg P, Pesce R, Cohen B, Cohen E, Witt B. Retrieval and in vitro maturation of
germinal vesicle bearing oocytes from women undergoing tubal ligation. In: 7th World Congress
on In Vitro Fertilizion; 1991 June 30 - July 3; Paris, France; 1991.
42. Barg P, Novogrodsky R, Barad D, Fisch H. Sperm penetration assay (SPA) results in patients
with abnormal sperm morphology In: American Fertility Society 1992 November 1992; 1992.
43. Barg P, Spitzer C, Barad D. High frequency of morphology abnormalities in frozen donor sperm
In: American Fertility Society 1992 November 1992; 1992.
44. Cohen B, Palan P, Barad D, Witt B, Zaratzian A, Romney S. Ovarian follicular fluid Betacarotene
levels in IVF cycles In: American Fertility Society 1992 November 1992; 1992.
45. Freeman R, Benedict A, Barad D. The effect of swimming on bone density of women aged 60-85
In: North American Menopause Society 1992 September 1992 1992.
46. Freeman R, Thornhill B, Haberman S, Barad D. Vertebral bone density is reduced by smoking
but not by hypeprolactinenia In: American Fertility Society 1992 November 1992 1992.
47. Freeman R, Mukherjee T, Turk R, Barad D. Comparison of Dexa bone density in women with
endometriosis or leiomyomata In: Society for Gynecological Investigion 1992 March 1992 1992.
48. Freeman R, Barad D. Smoking decreases bone density in premenopausal women but not in
postmenopausal women In: 49th American Fertility Society 1993 October 1993; Montreal,
Canada 1993.
49. Witt B, Barad D, Cohen B, Pollard J. Colony stimulating factor-1 in human follicular fluid In:
4oth Annual meeting of the Society for Gynecological Investigion 1993 April 1993; Toronto,
Canada 1993.
50. Amin H, Witt B, Testaiuti L, Cohen B, Lindheim S, Barg P, Barad D. Donor insemination: Cycle
day 3 serum follicle stimulating hormone (FSH) and estradiol as predictors of pregnancy. In:
Presented at the 50th American Fertility Society; 1994 November 5-10, 1994; San Antonio,
Texas; 1994.
51. Freeman R, Schwalb T, Barad D. Ambulatory blood pressure before and after estrogen
replacement therapy with pemarin or estraderm patches In: 50th American Fertility Society 1994
November 5-10, 1994 San Antonio 1994.
52. Lindheim S, Barg P, Testauiti L, Cohen B, Witt B, Amin H, Barad D. A comparison of treatment
regimens in the poor responder in an In Vitro Fertilization (IVF) program In: 50th American
Fertility Society 1994 November 5-10, 1994 San Antonio, TX 1994.
53. Barad D, Lindheim S, Zinger M, Witt B, Cohen B, Amin H, Fisch H, Barg P. Sperm morphology
predicts pregnancy more accurately after intrauterine insemination than after in vitro fertilization
In: American Society for Reproductive Medicine 51rst Annual Meeting 1995 Oct 7-12, 1995
1995.
54. Barg P, Lindheim, SR, Zinger M, Spitzer C, Amin H, Cohen B, Witt B, Fisch H, Barad D.
CV David Barad Page 23

Predictive Value of Single Versus Multiple Morphological Assessment of Spermatozoa after in
Vitro Fertilization In: American Society for Reproductive Medicine 51rst Annual Meeting 1995
Oct 7-12, 1995 1995.
55. Cohen B, Barad D. Design for resident education in reproductive endocrinology In:
CREOG/APGO Orlando FL 1995 March 8-11, 1995 1995.
56. Zinger M, Zapantis G, Amin H, Cohen B, Witt B, Barg P, Barad D, Lindheim S. Implantation
and pregnancy rates among recipients of different ages. In: 43rd Pacific Coast Fertility Society;
1995 April 26-30, 1995; 1995.
57. Zinger M, Zapantis G, Amin H, Cohen B, Witt B, Barg P, Barad D, Lindheim S. Pre and posthCG
progesterone are not predictive of pregnancy outcome in IVF-ET cycles In: 43rd Pacific
Coast Fertility Society 1995 April 26-30, 1995 1995.
58. Goluboff E, Fisch H, Diamond B, Olson J, Bierbaum R, Feldshuh J, Broder S, Seaman E, Barad
D, Olsson C. Semen analysis in 1283 men from the united states over a 25 year period. In:
American Urology Society; 1996; 1996.
59. Kaali S, Barad D, Merkatz I. Comparison of the abdominal wall stability of Endopath Optiview
with the standard laparoscopic trocar In: AAGL 25th Annual Meeting 1996 September 24-29,
1996 Chicago Ill 1996.
60. Kaali SG, Barad DH, Merkatz IR. Comparison of the Abdominal Wall Stability of Endopath
Optiview with the Standard Laparoscopic Cannula. J Am Assoc Gynecol Laparosc 1996;3(4,
Supplement):S19.
61. Lieman H, Robins J, Barad D. The use of a Urologic Stone Basket for Endometrial Polypectomy.
In: American Society of Reproductive Medicine; 1997 October 16-18; Cincinatti, Ohio; 1997.
62. Bevalaqua K, Barad D, Youchah J, Witt B. Is affect Associated with infertility treatment
outcome-. In: American Society for Reproductive Medicine 54th Annual Meeting; 1998 Oct 4-9,
1998; San Francisco, CA; 1998.
63. Barg PE, Barad DH, Witt BR, Amin HK. Availability of Cryopreservable Embryos of Good
Quality Predicts Cycle Success and High Order Multiple Gestation. Fertility and Sterility
2000;74(3, Supplement 1):S151.
64. Bevilacqua K, Barad D, Youchah J, Witt B. Infertility Patients: Communication within Couples.
Fertility and Sterility 2000;74(3, Supplement 1):S189.
65. Chervenak JL, Swigar M, Barad DH, Bevilacqua K, Lai YL, Santoro N. Reduced Cognitive
Performance by Estradiol Is Reversed by Progesterone in Perimenopausal Women. Fertility and
Sterility 2000;74(3, Supplement 1):S235-S6.
66. Pollack SE, Tang JJ, Barad DH. An Incompletely Resected, Obstructing Longitudinal Vaginal
Septum Causing Copious Mucus Discharge. Fertility and Sterility 2000;74(3, Supplement 1):S14.
67. Pollack SE, Kovacs P, Chervenak JL, Lieman HJ, Barad DH, Witt BR. Screening Saline
CV David Barad Page 24

Hysterosonography Predicts Intrauterine Pathology in Women Undergoing In Vitro Fertilization.
Fertility and Sterility 2000;74(3, Supplement 1):S235.
68. Bevilacqua K, Barad DH. Towards a behavioral picture of infertility patients. Fertility and
Sterility 2001;76(3, Supplement 1):S198-S9.
69. Jindal SK, Gatzen C, Barad D. Use of gonadotropin releasing hormone (GnRH) antagonist vs
agonist in repeat stimulation cycles of poor responders. Fertility and Sterility
2002;78(Supplement 1):S151.
70. Kovacs P, Pal L, Witt BR, Barad DH. Blastomere survival during cryopreservation is directly
related to pregnancy rate following FET. Fertility and Sterility 2002;78(Supplement 1):S127.
71. Kovacs P, Pal L, Barad DH. Progesterone level on the day of HCG injection adversely affects
blastomere survival during cryopreservation. Fertility and Sterility 2002;78(Supplement 1):S130-
S1.
72. Goudas VT, Jindal SK, Chudnoff S, Witt BR, Barad DH, Santoro NF. Ovarian reserve and cycle
number predict success of superovulation and intrauterine inseminations. Fertility and Sterility
2003;80(Supplement 3):156-7.
73. Barad DH, Weghofer A, Gleicher N. How predictive of basic pregnancy potential are extremely
low levels of anti-Müllerian hormone (AMH)? 65th Annual Meeting of the American Society for
Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.
74. Weghofer A, Dietrich W, Ortner I, Barad DH, Biegelmayer C, Gleicher N. Age-specific anti-
Mullerian hormone (AMH) in a fertile cohort: not as stable as previously thought. 26th Annual
Meeting of ESHRE, Rome, Italy, June 27-30, 2010.
75. Barad D, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by
heterozygousnormal/low genotype on the FMR1 (fragile X) gene. 26th Annual Meeting of
ESHRE, Rome, Italy, June 27-30, 2010.
76. Gleicher N, Barad DH. A new concept of ovarian aging: oocytes remain perpetually "young"; it is
the ovarian environment in which folliculogenesis occurs that ages. 26th Annual Meeting of
ESHRE, Rome, Italy, June 27-30, 2010.
77. Gleicher N, Barad DH. Evidence based medicine (EBM): what’s next? Cannot replace clinical
judgment. Proceedings of the 13th World Congress on Controversies in Obstetrics, Gynecology
& Infertility (COGI), Berlin, Germany, Nov. 4-7, 2010; Ben-Rafael Z ed, Monduzzi Editore
2010, p161-6.
78. Gleicher N, Weghofer A, Barad DH. Preimplantation genetic screening (PGS) is an experimental
tool that should be banned from routine clinical use: PGS, as currently practiced, is associated
with inferior results and should not be routinely offered. Idem; pp171-5.
79. Gleicher N, Weghofer A, Barad DH. Has anti-Müllerian hormone (AMH) become essential in
assessing ovarian reserve? – NO. Idem; pp189-94.
CV David Barad Page 25

80. Gleicher N, Weghofer A, Barad DH. Can diminished ovarian reserve be treated effectively? –
YES. Idem; pp195-201.
CV David Barad Page 26

Biography
Dr. Barad an Associate Clinical Professor with joint appointment in the departments of Epidemiology and Social
Medicine and Obstetrics and Gynecology at the Albert Einstein College of Medicine. From July 1984 until April
2001, Dr. Barad, MD served on the full time faculty of the Albert Einstein College of Medicine, where he was an
Associate Professor in the Department of Obstetrics and Gynecology & Women’s Health. He also served as the
Director of the Division of Reproductive Endocrinology in the Department of Obstetrics and Gynecology at the
Montefiore Medical Center. He is a 1972 graduate of Rutgers College and a 1978 graduate of Rutgers Medical
School (now known as Robert Wood Johnson Medical School). Dr. Barad completed his residency in Obstetrics and
Gynecology at Columbia Presbyterian Medical Center in 1982. Dr. Barad went on to sub-specialty training in the
Reproductive Endocrinology Fellowship at the Brigham and Women’s Hospital of Harvard Medical School. He
finished his fellowship at Harvard in 1984. In 2003 Dr. Barad received a Masters of Science in the Clinical
Research Training Program at the Albert Einstein College of Medicine. Dr. Barad is a Co-investigator in the
Women’s Health Initiative and is Chair of the WHI Hormone Advisory Committee. The WHI is the largest and
longest clinical trial of both diet and hormone replacement therapy ever conducted. Dr. Barad’s research covers a
broad range of interests including postmenopausal hormone treatment, osteoporosis, and postmenopausal symptoms
as well as ovarian function, ovulation induction and in vitro fertilization. Dr. Barad presently practices in Manhattan
at the Center for Human Reproduction, where he is Director of Assisted Reproductive Technology. Dr. Barad is on
the Voluntary Staff of St Luke’s Roosevelt Hosptial as an Associate Attending in the Depart of Obstetrics and
Gynecology.
Dr. Barad has published extensively in the field of reproductive endocrinology and has achieved a national and
international reputation in that discipline. He is the recipient of the 1996 Kokopelli Ball Resolve of New York City
Chapter Award for “outstanding dedication and commitment to family building”.
CV David Barad Page 27